Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics Inc., an oncology company focused on developing more effective cancer treatments through its nanotechnology platform, announced the launch of a new division, Parexo Labs, a contract development and manufacturing organization (CDMO) providing chemical testing and liposomal manufacturing services to outside organizations. Parexo Labs leverages Azaya’s twin capabilities in cytotoxic and nanoparticle analysis and liposome manufacturing, including its proprietary analytical methodology to detail release rates and characterization attributes of nanoparticles. Parexo Labs offers laboratory services that can speed drug development and regulatory progress for pharmaceutical and medical device developers alike.
Help employers find you! Check out all the jobs and post your resume.
SAN ANTONIO--(BUSINESS WIRE)--Azaya Therapeutics Inc., an oncology company focused on developing more effective cancer treatments through its nanotechnology platform, announced the launch of a new division, Parexo Labs, a contract development and manufacturing organization (CDMO) providing chemical testing and liposomal manufacturing services to outside organizations. Parexo Labs leverages Azaya’s twin capabilities in cytotoxic and nanoparticle analysis and liposome manufacturing, including its proprietary analytical methodology to detail release rates and characterization attributes of nanoparticles. Parexo Labs offers laboratory services that can speed drug development and regulatory progress for pharmaceutical and medical device developers alike.
Help employers find you! Check out all the jobs and post your resume.
